Dr Musa Abdulkareem is Principal Research Scientist on the Barts Life Sciences CAP-AI programme, where he has been working with Professor Steffen Petersen from Queen Mary University of London to use Artificial Intelligence in analysing cardiac MRI scans. In this Q&A, Dr Abdulkareem reflects on the progress of the project over the last 15 months and talks about his...
UK Research and Innovation (UKRI) has awarded funding to Queen Mary University of London, as part of the Barts Life Sciences partnership, to develop a proposal for data-driven next generation healthcare in Whitechapel. Led by Barts Life Sciences, the project will harness artificial intelligence and data technology to provide better healthcare for patients living in East London, specifically Whitechapel, where chronic health problems are significantly...
In this project we are interested in preventing diabetic foot disease. 1 in 10 patients with diabetes will get a foot ulcer but some of these will not-fully heal, recur, or become infected and may eventually require a lower limb amputation. We know some factors that increase risk of developing diabetic foot – such as smoking, poor blood circulation and...
Barts Life Sciences (BLS) – a partnership between Queen Mary and Barts Health NHS Trust with the generous support of Barts Charity – is leading a new initiative to embed computer sciences at a senior level within Queen Mary to catalyse innovative precision medicine and population health research. BLS is recruiting three new professors in computer health sciences who will – with the generous package of support...
Barts Life Sciences is leading on COVID-19 research projects working closely with teams from Barts Health and Queen Mary University of London: https://www.bartshealth.nhs.uk/covid19-research https://www.qmul.ac.uk/media/news/2020/smd/queen-mary-and-barts-health-launch-covid-19-research-programme.html
Barts Life Sciences is delighted to support QMUL’s University Enterprise Programme: Queen Mary University of London has a proven record of success as a science incubator. QME is our latest step to help life sciences companies grow and scale. We’re proud to have financed, designed and built the largest purpose-built innovation centre in London – QMB Innovation Centre – 100% filled with tenants....
Barts Life Sciences CAP-AI principal investigator James Moon and senior data scientist Rhodri Davies launch world first: https://www.dailymail.co.uk/health/article-8003697/Worlds-AI-predict-patients-heart-attack-stroke-better-DOCTOR.html
To mark International Clinical Trials Day, Queen Mary University of London and Barts Health NHS Trust have released a range of new resources to encourage people to get involved in COVID-19 research projects. https://www.qmul.ac.uk/media/news/2020/smd/more-than-1500-people-recruited-to-covid-19-research-projects.html
Queen Mary University of London and Barts Health NHS Trust, as part of their Barts Life Sciences initiative, have begun a new programme of Covid-19 research across Barts Health hospitals, including NHS Nightingale Hospital London. https://www.qmul.ac.uk/media/news/2020/smd/queen-mary-and-barts-health-launch-covid-19-research-programme.html
Barts Life Sciences are pleased to announce that we will be an exhibitor at SEHTA’s 2020 International MedTech Expo & Conference, which is taking place on 26th March 2020 at the Hilton Tower Bridge Hotel, London. Come along and join us for this prestigious event to meet like-minded organisations and SMEs involved in Digital, Devices and Diagnostics. Speaking at the...
Accessibility options
Translate the page